Stock comparison
ELI LILLY & Co is 97.4x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($1.115 T vs $11.45 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 97.4x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($1.115 T vs $11.45 B).
Market value leader
LLY
ELI LILLY & Co is 97.4x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($1.115 T vs $11.45 B).
Revenue leader
LLY
BMRN: $3.22B vs LLY: $65.18B.
Profit leader
LLY
BMRN: $348.90M vs LLY: $20.64B.
Margin leader
LLY
BMRN: 10.8% vs LLY: 31.7% net margin.
| Metric | BMRN | LLY |
|---|---|---|
| Market cap | $11.45 B | $1.115 T |
| US-listed rank | #873 | #11 |
| Revenue (latest FY) | $3.22B | $65.18B |
| Net income (latest FY) | $348.90M | $20.64B |
| Net margin | 10.8% | 31.7% |
| P/E (trailing FY) | 32.8x | 54.0x |
| SEC filings | 2,709 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 97.4x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($1.115 T vs $11.45 B).
In their latest fiscal years, BIOMARIN PHARMACEUTICAL INC reported $3.22B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: BIOMARIN PHARMACEUTICAL INC and ELI LILLY & Co, or browse the full rankings.